A lot of sins will be forgiven if the distribution deal is as good as Mark has indicated.And even more so if the capital raising terms involve little/no dilution.Here's hoping he hits both pitches out of the park.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
